{
    "772d13c7-fc59-3472-a5eb-7a13c4470c64": {
        "uuid": "772d13c7-fc59-3472-a5eb-7a13c4470c64",
        "title": "Novavax\u2019s Covid-19 Vaccine Doses Shipped for Use in U.S.",
        "publisher": "The Wall Street Journal",
        "link": "https://finance.yahoo.com/m/772d13c7-fc59-3472-a5eb-7a13c4470c64/novavax%E2%80%99s-covid-19-vaccine.html",
        "providerPublishTime": 1658526900,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/bDC2YLfX.klj18iSHh75aA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/g_nQKtJyiZyQeMJBToKZDQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/2e4751253d7160428bf1866831b94a3e",
                    "width": 1280,
                    "height": 640,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/JRkA7HbFAOcmHXGpB_tgKA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/g_nQKtJyiZyQeMJBToKZDQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/2e4751253d7160428bf1866831b94a3e",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "NVAX"
        ]
    },
    "8606475c-2263-3bc3-b00c-93962f2d3e39": {
        "uuid": "8606475c-2263-3bc3-b00c-93962f2d3e39",
        "title": "Why Novavax Stock Is Down More Than 7% Today",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/8606475c-2263-3bc3-b00c-93962f2d3e39/why-novavax-stock-is-down.html",
        "providerPublishTime": 1658514862,
        "type": "STORY",
        "relatedTickers": [
            "NVAX"
        ]
    },
    "7c7600a5-1e38-331d-861e-2781c228bb34": {
        "uuid": "7c7600a5-1e38-331d-861e-2781c228bb34",
        "title": "Novavax Wins FDA OK For Covid Shot, But Collapses \u2014 Is It A Buy Or A Sell?",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/7c7600a5-1e38-331d-861e-2781c228bb34/novavax-wins-fda-ok-for-covid.html",
        "providerPublishTime": 1658506587,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/PBn7noB8AeKj3peetm2EQA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/umQFRfxqba3vcRJTALMEiQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/636ee75ec8da00572fff6497e27e7681",
                    "width": 1000,
                    "height": 563,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/Zgssmb6s2b_mKniSXsCCGA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/umQFRfxqba3vcRJTALMEiQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/636ee75ec8da00572fff6497e27e7681",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "NVAX"
        ]
    },
    "65409247-b6a4-36c7-be89-5777626d54db": {
        "uuid": "65409247-b6a4-36c7-be89-5777626d54db",
        "title": "Is This Vaccine Stock a Buy After Big News?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/65409247-b6a4-36c7-be89-5777626d54db/is-this-vaccine-stock-a-buy.html",
        "providerPublishTime": 1658486700,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/Ai7mRY.uNHA044fY2MF5rw--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/LdrjPPfPAjvYgGzVSizNxw--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9d84f4b3ee4aa70d4955ece67b933951",
                    "width": 1400,
                    "height": 787,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/B0rT6Zw7fpsyn7ko0qqtNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/LdrjPPfPAjvYgGzVSizNxw--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9d84f4b3ee4aa70d4955ece67b933951",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "NVAX",
            "MRNA",
            "PFE"
        ]
    },
    "b6f8be1c-f607-4766-b8cc-8a1a2bd85f9d": {
        "uuid": "b6f8be1c-f607-4766-b8cc-8a1a2bd85f9d",
        "title": "Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval",
        "publisher": "Yahoo Finance",
        "link": "https://finance.yahoo.com/news/novavax-ceo-covid-19-vaccine-demand-cdc-approval-101850865.html",
        "providerPublishTime": 1658485130,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/Fr04zuP1fHVJmzRxV9aZ6A--~B/aD0xNDgwO3c9MjI4NDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2022-06/792d2be0-f848-11ec-bfad-8e7ab9778efb",
                    "width": 2284,
                    "height": 1480,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/bsgUd4AWEIziVG3Ai_akPw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/os/creatr-uploaded-images/2022-06/792d2be0-f848-11ec-bfad-8e7ab9778efb",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "BNTX",
            "NVAX",
            "AZN",
            "AZNCF",
            "JNJ",
            "PFE"
        ]
    },
    "0dc40d32-2c6f-337c-a425-e8068c58ab9c": {
        "uuid": "0dc40d32-2c6f-337c-a425-e8068c58ab9c",
        "title": "Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/novavax-nvax-stock-sinks-market-215009930.html",
        "providerPublishTime": 1658440209,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/UxwOzvHDNBTF_fS7HMDV3w--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
                    "width": 900,
                    "height": 601,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/Pxzh3AGGzUkhMRlhJidIqQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "NVAX",
            "^GSPC"
        ]
    },
    "da5dc9ac-b9f8-3dd8-8460-c282162e8e64": {
        "uuid": "da5dc9ac-b9f8-3dd8-8460-c282162e8e64",
        "title": "Novavax COVID-19 vaccine will be available \u2018next week,\u2019 CEO says",
        "publisher": "Yahoo Finance Video",
        "link": "https://finance.yahoo.com/video/novavax-covid-19-vaccine-available-161304941.html",
        "providerPublishTime": 1658419984,
        "type": "VIDEO",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/pDiuCLykGxZVNopKCDKczQ--~B/aD0xNTYwO3c9Mjc3OTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2022-07/fc48c3e0-090f-11ed-99ff-788b424dc051",
                    "width": 2779,
                    "height": 1560,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/3NyfemBXu4mhsd4j5EOWjg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/os/creatr-uploaded-images/2022-07/fc48c3e0-090f-11ed-99ff-788b424dc051",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "PFE",
            "NVAX",
            "JNJ",
            "BNTX",
            "MRNA"
        ]
    },
    "14677c1b-9eb0-36f5-b697-e64044ad4f1e": {
        "uuid": "14677c1b-9eb0-36f5-b697-e64044ad4f1e",
        "title": "Is It Too Late to Buy Novavax Stock?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/14677c1b-9eb0-36f5-b697-e64044ad4f1e/is-it-too-late-to-buy-novavax.html",
        "providerPublishTime": 1658416020,
        "type": "STORY",
        "relatedTickers": [
            "NVAX"
        ]
    }
}